Vision Monday VMail Weekend

July 1 and 2, 2023|


Keeping a Close ‘Eye’ on Fireworks Safety This Fourth of July

Nothing says summer like Fourth of July family barbecues, beach gatherings, trips to a favorite amusement park, and fireworks. Many of these gatherings on our nation’s birthday conclude with a fireworks display, with most as spectators and others as active participants. But just how safe are fireworks in terms of overall injuries and specifically ocular injuries and what precautions can be taken in order to avoid an uninvited Independence Day disruption? Eyecare professionals can play a critical role in knowing about what can happen and making sure to warn patients and parents about some of the dangers.
Read More

In Case you Missed It - VMail's Top Stories of the Week

Bausch + Lomb will acquire Xiidra from Novartis; Supreme Court decision creates concerns and renewed commitment from optometry groups; VM’s presbyopia update explores 'What’s New for Older Eyes'; AOA signs the 13% Promise; and VM releases 2023 Top 50 U.S. Optical Retailers report all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

Bausch + Lomb Will Acquire Xiidra from Novartis

Supreme Court Decision Striking Down Affirmative Action in College Admissions Creates Concerns and Renewed Commitment from Optometry Groups

VM’s Presbyopia Update Explores 'What’s New for Older Eyes'

American Optometric Association Signs the 13% Promise, to Advance Opportunities for Today and Tomorrow's Black Optometrists

For VM's 2023 Top 50 U.S. Optical Retailers, Consolidation and Organic Growth Continue as New Players Emerge

Insta Pick - Noteworthy Posts From the People We Follow

Editor's Pick

Bausch + Lomb Will Acquire Xiidra from Novartis

VAUGHAN, Ontario—Bausch + Lomb Corp. (NYSE/TSX: BLCO) announced it has entered into a definitive agreement with Novartis under which Bausch + Lomb will acquire Xiidra (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) focusing on inflammation associated with dry eye. “This acquisition is a prime example of our strategy in action, as it provides needed scale for the company and transforms our pharmaceuticals business by making us a leader in ocular surface diseases,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “The deal is also expected to accelerate margin expansion through a larger mix of pharmaceutical products in our portfolio, provide strong and immediate earnings accretion and presents a clear path to deleverage, making it financially compelling.”
Read More


Tweet of the Week

We Share It

This hair clip is the perfect summer accessory. You can purchase it on Etsy here. #WeShareIt

Optical on Main Street

A Juneteenth Celebration

NEW YORK—In 2021, President Biden declared Juneteenth a federal holiday, firmly cementing the importance of this holiday that has long been celebrated in the U.S. Juneteenth, which falls on June 19 each year, commemorates the end of slavery in the U.S.—it does not mark the day that President Lincoln signed the Emancipation Proclamation, but rather the day two years later when Union Army Major General Gordon Granger rode into Galveston, Texas and informed enslaved people there of their freedom, CNN reported.
Read More


Interested in more from VisionMonday and VMail? Click here to subscribe to our other e-newsletters.

VMail Weekend is published by Jobson Medical Information LLC, 395 Hudson Street, New York, NY 10014.

To subscribe to other JMI newsletters or to manage your subscription, click here.